多药
医学
药方
全国健康与营养检查调查
社会经济地位
蛋白尿
药物依从性
老年学
急诊医学
内科学
人口
环境卫生
疾病
药理学
作者
Shaoxi Pan,Shanshan Li,Shaoxiang Jiang,Jung‐Im Shin,Gordon G. Liu,Hongyan Wu,Beini Lyu
出处
期刊:The Journals of Gerontology
[Oxford University Press]
日期:2024-04-22
卷期号:79 (7)
被引量:1
标识
DOI:10.1093/gerona/glae108
摘要
Abstract Background Contemporary data on the quantity and quality of medication use among older adults are lacking. This study examined recent trends in the number and appropriateness of prescription medication use among older adults in the United States. Methods Data from the National Health and Nutrition Examination Survey (NHANES) between 2011 and March 2020 were used, and 6 336 adult participants aged 65 and older were included. We examined the number of prescription medication, prevalence of polypharmacy (≥5 prescription drugs), use of potentially inappropriate medication (PIM), and use of recommended medications (angiotensin-converting enzyme inhibitor [ACEI]/angiotensin receptor blockers [ARBs] plus beta-blockers among patients with heart failure and ACEI/ARBs among patients with albuminuria). Results There has been a slight increase in the prevalence of polypharmacy (39.3% in 2011–2012 to 43.8% in 2017–2020, p for trend = .32). Antihypertensive, antihyperlipidemic, antidiabetic medications, and antidepressants are the most commonly used medications. There was no substantial change in the use of PIM (17.0% to 14.7%). Less than 50% of older adults with heart failure received ACEI/ARBs plus beta-blockers (44.3% in 2017–2020) and approximately 50% of patients with albuminuria received ACEI/ARBs (54.0% in 2017–2020), with no improvement over the study period. Polypharmacy, older age, female, and lower socioeconomic status were generally associated with greater use of PIM but lower use of recommended medications. Conclusions The medication burden remained high among older adults in the United States and the appropriate utilization of medications did not improve in the recent decade. Our results underscore the need for greater attentions and interventions to the quality of medication use among older adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI